Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
AU2013204964B2 - Activin-actriia antagonists and uses for treating or preventing breast cancer - Google Patents
[go: Go Back, main page]

AU2013204964B2 - Activin-actriia antagonists and uses for treating or preventing breast cancer - Google Patents

Activin-actriia antagonists and uses for treating or preventing breast cancer

Info

Publication number
AU2013204964B2
AU2013204964B2 AU2013204964A AU2013204964A AU2013204964B2 AU 2013204964 B2 AU2013204964 B2 AU 2013204964B2 AU 2013204964 A AU2013204964 A AU 2013204964A AU 2013204964 A AU2013204964 A AU 2013204964A AU 2013204964 B2 AU2013204964 B2 AU 2013204964B2
Authority
AU
Australia
Prior art keywords
activin
treating
breast cancer
preventing breast
actriia antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2013204964A
Other versions
AU2013204964A1 (en
Inventor
John Knopf
Ravindra Kumar
Jasbir Seehra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Acceleron Pharma Inc
Original Assignee
Acceleron Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2008211007A external-priority patent/AU2008211007B2/en
Application filed by Acceleron Pharma Inc filed Critical Acceleron Pharma Inc
Priority to AU2013204964A priority Critical patent/AU2013204964B2/en
Publication of AU2013204964A1 publication Critical patent/AU2013204964A1/en
Priority to AU2016202059A priority patent/AU2016202059A1/en
Application granted granted Critical
Publication of AU2013204964B2 publication Critical patent/AU2013204964B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

AU2013204964A 2007-02-01 2013-04-12 Activin-actriia antagonists and uses for treating or preventing breast cancer Active AU2013204964B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2013204964A AU2013204964B2 (en) 2007-02-01 2013-04-12 Activin-actriia antagonists and uses for treating or preventing breast cancer
AU2016202059A AU2016202059A1 (en) 2007-02-01 2016-04-01 Activin-actriia antagonists and uses for treating or preventing breast cancer

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US60/899,070 2007-02-01
US61/000,540 2007-10-25
AU2008211007A AU2008211007B2 (en) 2007-02-01 2008-02-01 Activin-ActRIIa antagonists and uses for treating or preventing breast cancer
AU2013204964A AU2013204964B2 (en) 2007-02-01 2013-04-12 Activin-actriia antagonists and uses for treating or preventing breast cancer

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2008211007A Division AU2008211007B2 (en) 2007-02-01 2008-02-01 Activin-ActRIIa antagonists and uses for treating or preventing breast cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2016202059A Division AU2016202059A1 (en) 2007-02-01 2016-04-01 Activin-actriia antagonists and uses for treating or preventing breast cancer

Publications (2)

Publication Number Publication Date
AU2013204964A1 AU2013204964A1 (en) 2013-05-16
AU2013204964B2 true AU2013204964B2 (en) 2016-05-12

Family

ID=

Similar Documents

Publication Publication Date Title
IL200186A0 (en) Activin-actriia antagonists and uses for treating or preventing breast cancer
IL257681A (en) Methods and compositions for treating cancer
PL2200431T3 (en) Novel compositions and methods for cancer treatment
SI2173379T1 (en) Compositions and methods for treating and diagnosing cancer
ZA200807934B (en) Cancer treatments
PL2101731T3 (en) Endoxifen for use in the treatment of cancer
ZA201005248B (en) 4-pyridinone compounds and their use for cancer
SI2187967T1 (en) Methods and compositions for treating cancers
IL199911A0 (en) 3-cinnolinecarboxamide derivatives and their use for treating cancer
IL206189A0 (en) Compound for use in the treatment of cancer
GB0707556D0 (en) Treatment for cancer
IL226362A0 (en) Compounds, and methods for the treatment of cancer
AU2013204964B2 (en) Activin-actriia antagonists and uses for treating or preventing breast cancer
WO2009055506A9 (en) Aminoflavone (nsc 686288) and combinations thereof for treating breast cancer
IL205339A0 (en) Compounds and methods for the treatment of cancer
GB0710871D0 (en) Cancer treatment
HK1138590A (en) 3-cinnolinecarboxamide derivatives and their use for treating cancer
GB0619271D0 (en) Treating cancer
GB0700493D0 (en) Cancer treatment
GB0723503D0 (en) Cancer treatment
GB0604741D0 (en) Cancer Treatment
GB0618199D0 (en) Cancer treatment
GB0604114D0 (en) Combinations for the treatment of cancer
GB0700281D0 (en) Methods and Means for the Treatment of Cancer
PT3067054T (en) Novel compositions and methods for cancer treatment